PMID: 4394527Aug 1, 1970Paper

Central hypotensive effect of L-3,4-dihydroxyphenylalanine in the rat

The Journal of Pharmacy and Pharmacology
M Henning, A Rubenson

Abstract

No abstract listed.

References

Feb 13, 1969·The New England Journal of Medicine·G C CotziasR Gellene
Apr 12, 1969·Lancet·D B CalneP Armitage
Oct 4, 1969·Lancet·I L Hansteen
May 1, 1969·The Journal of Pharmacy and Pharmacology·G Bartholini, A Pletscher
Sep 1, 1969·The Journal of Pharmacy and Pharmacology·L L Butcher, J Engel
Oct 1, 1969·European Journal of Pharmacology·T P Pruss, J S McGill
May 1, 1970·Life Sciences·N E AndénT Svensson
Mar 1, 1970·The Journal of Pharmacy and Pharmacology·M Henning, A Rubenson
Oct 1, 1969·Archives of Neurology·M D YahrM M Hoehn
Dec 15, 1958·Acta Physiologica Scandinavica·A BERTLERE ROSENGREN
Jan 1, 1962·Acta Physiologica Scandinavica·A CARLSSON, M LINDQVIST
Nov 1, 1962·Biochemical Pharmacology·C C PORTERS S BYER
Oct 2, 1964·Acta Neurovegetativa·A CARLSSON
Jul 1, 1960·Journal of Applied Physiology·V POPOVIC, P POPOVIC

❮ Previous
Next ❯

Citations

Jan 1, 1971·Psychopharmacologia·J MajE Mogilnicka
Jan 1, 1972·Naunyn-Schmiedeberg's Archives of Pharmacology·G HaeuslerH Thoenen
Aug 1, 1976·Naunyn-Schmiedeberg's Archives of Pharmacology·C GomesG Trolin
Jan 1, 1972·Naunyn-Schmiedeberg's Archives of Pharmacology·N E AndénA Rubenson
Jan 1, 1972·Naunyn-Schmiedeberg's Archives of Pharmacology·N E AndénA Rubenson
Jan 1, 1976·Journal of Neural Transmission·C GomesG Trolin
Jan 16, 1976·Clinica Chimica Acta; International Journal of Clinical Chemistry·B WocialB Skórka
Feb 1, 1972·European Journal of Pharmacology·H R KaplanS A La Sala
May 1, 1973·European Journal of Pharmacology·H Schmitt, S Fenard
Mar 1, 1973·European Journal of Pharmacology·L Finch, G Haeusler
Feb 1, 1973·European Journal of Pharmacology·U UngerstedtB Anagnoste
Nov 1, 1974·European Journal of Pharmacology·W De Jong
Mar 4, 1983·European Journal of Pharmacology·P JohanssonM Henning
Jun 3, 1983·European Journal of Pharmacology·P JohanssonM Henning
Jul 16, 1979·Life Sciences·T T YenJ A Clemens
Jan 1, 1975·Pharmacology & Therapeutics. Part B: General & Systematic Pharmacology·A Carlsson
Jan 1, 1981·Comparative Biochemistry and Physiology. C: Comparative Pharmacology·P Johansson, M Henning
Jan 1, 1981·Comparative Biochemistry and Physiology. C: Comparative Pharmacology·M Henning, P Johansson
Aug 1, 1994·Journal of the American College of Cardiology·J SchutzmanF Fouad-Tarazi
Jan 1, 1983·Comparative Biochemistry and Physiology. C, Comparative Pharmacology and Toxicology·P Johansson
Mar 6, 2003·Parkinsonism & Related Disorders·K F BhattacharyaH Kaufmann
Apr 15, 1971·The New England Journal of Medicine·G D FinlayL I Goldberg
Jan 27, 1972·The New England Journal of Medicine·L Landsberg
Jan 1, 1982·Journal of the American Academy of Child Psychiatry·D H LangerW E Bunney
Jan 1, 1972·British Journal of Pharmacology·D B CalneS D Vakil
Mar 1, 1973·British Journal of Pharmacology·K M Dhasmana, B A Spilker
Aug 1, 1974·British Journal of Pharmacology·E Eden, P A Nasmyth
May 22, 1971·British Medical Journal·A S SpiersT M French
Nov 11, 1972·British Medical Journal·W J LouisM J Robinson
Jun 1, 1973·Journal of Neurology, Neurosurgery, and Psychiatry·M J AminoffM Kremer
Apr 1, 1981·Journal of Neurology, Neurosurgery, and Psychiatry·A J Lees, R Bannister
Jun 1, 1971·The Journal of Clinical Investigation·A M WatanabeI J Kopin
Jul 25, 2014·Experimental Neurology·Valentina PendolinoBarbara Picconi
Jul 1, 1974·Clinical and Experimental Pharmacology & Physiology·W J LouisR G Sampson

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.